Tuesday Pfizer announced it's expanding its clinical trials for younger children ages 5 to 11-years-old. Medical doctors are calling this the final frontier. This is a 2-year study, where a subset of ...
Smaller doses of Pfizer’s COVID-19 vaccine appear safe and more than 90% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released by the company on ...
Hosted on MSN
FDA may pull authorization of Pfizer's Covid vaccine for children under 5, company says
The Food and Drug Administration is considering revoking its authorization of Pfizer's Covid-19 vaccine for healthy children under the age of 5, the drugmaker confirmed to CNBC. The move could leave ...
Pfizer Inc.'s (NYSE:PFE) COVID-19 vaccine for children under five may lose U.S. Food and Drug Administration authorization this fall, raising the possibility of supply shortages and prompting Moderna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback